LAUREN RUTKOSKI: Open Payments
NPI 1992746341 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 85 payments from 19 companies in 2025. Trend: 2023 $1,875 · 2024 $1,878 · 2025 $1,594
Food & beverage: $1,514Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $248 |
| UCB, Inc. | 12 | $193 |
| Novartis Pharmaceuticals Corporation | 12 | $135 |
| Lilly USA, LLC | 2 | $124 |
| Galderma Laboratories, L.P. | 6 | $116 |
| GENZYME CORPORATION | 4 | $112 |
| Janssen Biotech, Inc. | 4 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, COSENTYX, NEMLUVIO, EBGLYSS, TREMFYA, Sotyktu.
Industry payments across NY — which companies pay providers there.
